Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma by Anjali Rohatgi, John M. Kirkwood

Get full text

Immunotherapy in Melanoma: Recent Advances and Future Directions by Andrew Knight, Lilit Karapetyan, John M. Kirkwood

Get full text

GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells by Laurence Booth, Cameron West, Daniel Von Hoff, John M. Kirkwood, Paul Dent

Get full text

Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations by Amalia Anastasopoulou, Dimitrios C. Ziogas, Michael Samarkos, John M. Kirkwood, Helen Gogas

Get full text

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease by Michael M. Boyiadzis, John M. Kirkwood, John L. Marshall, Colin C. Pritchard, Nilofer S. Azad, James L. Gulley

Get full text

Fluorescence Imaging Analysis of Upstream Regulators and Downstream Targets of STAT3 in Melanoma Precursor Lesions Obtained from Patients Before and After Systemic Low-Dose Interfe... by Amanda Pfaff Smith, John M. Kirkwood, Howard D. Edington, Drazen M. Jukic, Daniel L. Farkas, Dorothea Becker

Get full text

Prognostic gene expression profile testing to inform use of adjuvant therapy: A survey of melanoma experts by Suzanne Fastner, Nathan Shen, Rebecca I. Hartman, Emily Y. Chu, Caroline C. Kim, John M. Kirkwood, Douglas Grossman

Get full text

Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study by Ryan C. Augustin, Ryan C. Augustin, Ziyu Huang, Fei Ding, Shuyan Zhai, Jennifer McArdle, Anthony Santisi, Michael Davis, Cindy Sander, Diwakar Davar, John M. Kirkwood, John M. Kirkwood, Greg M. Delgoffe, Allison Betof Warner, Yana G. Najjar, Yana G. Najjar

Get full text

Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study by Nghi C. Nguyen, Melissa K. Yee, Abuzar M. Tuchayi, John M. Kirkwood, Hussein Tawbi, Hussein Tawbi, James M. Mountz

Get full text

Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis by Melissa L. Bastacky, Hong Wang, Dylan Fortman, Zahra Rahman, Gerard P. Mascara, Timothy Brenner, Yana G. Najjar, Yana G. Najjar, Jason J. Luke, Jason J. Luke, John M. Kirkwood, John M. Kirkwood, Hassane M. Zarour, Hassane M. Zarour, Diwakar Davar, Diwakar Davar

Get full text

A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon. by Ena Wang, Yingdong Zhao, Alessandro Monaco, Lorenzo Uccellini, John M Kirkwood, Maria Spyropoulou-Vlachou, Monica C Panelli, Francesco M Marincola, Helen Gogas

Get full text

Multiple primary melanoma in association with other personal and familial cancers by Xi Yang, Lilit Karapetyan, Ziyu Huang, Andrew D. Knight, Sneha Rajendran, Cindy Sander, Christopher P. Minnier, Melissa J. Wilson, John M. Kirkwood

Get full text

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma by Saba S. Shaikh, Saba S. Shaikh, Yan Zang, Janel Hanmer, Hong Wang, Yan Lin, Diwakar Davar, Hassane M. Zarour, John M. Kirkwood, Yana G. Najjar

Get full text

Circulating type-1 anti-tumor CD4+ T cells are preferentially pro-apoptotic in cancer patients by Amy K. Wesa, Maja eMandic, Jennifer L. Taylor, Stergios eMoschos, John M. Kirkwood, William W. Kwok, James Harold Finke, Walter J. Storkus

Get full text

CD56dim CD16− Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α by Lazar Vujanovic, Lazar Vujanovic, Christopher Chuckran, Yan Lin, Yan Lin, Fei Ding, Fei Ding, Cindy A. Sander, Cindy A. Sander, Patricia M. Santos, Patricia M. Santos, Joel Lohr, Afshin Mashadi-Hossein, Sarah Warren, Andy White, Alan Huang, John M. Kirkwood, John M. Kirkwood, Lisa H. Butterfield, Lisa H. Butterfield, Lisa H. Butterfield, Lisa H. Butterfield

Get full text

Psychosocial consequences of skin cancer screening by Patricia Markham Risica, Natalie H. Matthews, Laura Dionne, Jennifer Mello, Laura K. Ferris, Melissa Saul, Alan C. Geller, Francis Solano, John M. Kirkwood, Martin A. Weinstock

Get full text

Proteomic profile of melanoma cell‐derived small extracellular vesicles in patients’ plasma: a potential correlate of melanoma progression by Monika Pietrowska, Aneta Zebrowska, Marta Gawin, Lukasz Marczak, Priyanka Sharma, Sujan Mondal, Justyna Mika, Joanna Polańska, Soldano Ferrone, John M. Kirkwood, Piotr Widlak, Theresa L. Whiteside

Get full text

Early Cortisol and Inflammatory Responses to Parental Cancer and Their Impact on Functional Impairment in Youth by Benjamin Hayes, Jacob Brent, Yongqi Zhong, Shervin Bazmi, Giovanna Porta, Dana H. Bovbjerg, Ahmad Tarhini, John M. Kirkwood, David A. Brent, Anna Marsland, Nadine M. Melhem

Get full text

CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma. by Arjun Khunger, Erin Piazza, Sarah Warren, Thomas H Smith, Xing Ren, Andrew White, Nathan Elliott, Alessandra Cesano, Joseph M Beechem, John M Kirkwood, Ahmad A Tarhini

Get full text

Targeted Long-Read Bisulfite Sequencing Identifies Differences in the <i>TERT</i> Promoter Methylation Profiles between <i>TERT</i> Wild-Type and <i>TERT</i> Mutant Cancer Cells by Seungjae Lee, Ti-Cheng Chang, Patrick Schreiner, Yiping Fan, Neeraj Agarwal, Charles Owens, Reinhard Dummer, John M. Kirkwood, Raymond L. Barnhill, Dan Theodorescu, Gang Wu, Armita Bahrami

Get full text